Global Vulvar and Vaginal Atrophy Therapy Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Vulvar and Vaginal Atrophy Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Vulvar and Vaginal Atrophy Therapy Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Vulvar Atrophy Therapy
        1.3.3 Vaginal Atrophy Therapy
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Vulvar and Vaginal Atrophy Therapy Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Ambulatory Surgical Centers
        1.4.4 Specialty Clinics
        1.4.5 Others
    1.5 Global Vulvar and Vaginal Atrophy Therapy Market Size & Forecast
        1.5.1 Global Vulvar and Vaginal Atrophy Therapy Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Vulvar and Vaginal Atrophy Therapy Sales Quantity (2018-2029)
        1.5.3 Global Vulvar and Vaginal Atrophy Therapy Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 Almirall
        2.1.1 Almirall Details
        2.1.2 Almirall Major Business
        2.1.3 Almirall Vulvar and Vaginal Atrophy Therapy Product and Services
        2.1.4 Almirall Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Almirall Recent Developments/Updates
    2.2 VenusConcept
        2.2.1 VenusConcept Details
        2.2.2 VenusConcept Major Business
        2.2.3 VenusConcept Vulvar and Vaginal Atrophy Therapy Product and Services
        2.2.4 VenusConcept Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 VenusConcept Recent Developments/Updates
    2.3 Alma Lasers
        2.3.1 Alma Lasers Details
        2.3.2 Alma Lasers Major Business
        2.3.3 Alma Lasers Vulvar and Vaginal Atrophy Therapy Product and Services
        2.3.4 Alma Lasers Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Alma Lasers Recent Developments/Updates
    2.4 ThermiGen LLC
        2.4.1 ThermiGen LLC Details
        2.4.2 ThermiGen LLC Major Business
        2.4.3 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Product and Services
        2.4.4 ThermiGen LLC Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 ThermiGen LLC Recent Developments/Updates
    2.5 Lutronic
        2.5.1 Lutronic Details
        2.5.2 Lutronic Major Business
        2.5.3 Lutronic Vulvar and Vaginal Atrophy Therapy Product and Services
        2.5.4 Lutronic Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Lutronic Recent Developments/Updates
    2.6 BTL Group of Companies
        2.6.1 BTL Group of Companies Details
        2.6.2 BTL Group of Companies Major Business
        2.6.3 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Product and Services
        2.6.4 BTL Group of Companies Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 BTL Group of Companies Recent Developments/Updates
    2.7 Viveve
        2.7.1 Viveve Details
        2.7.2 Viveve Major Business
        2.7.3 Viveve Vulvar and Vaginal Atrophy Therapy Product and Services
        2.7.4 Viveve Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Viveve Recent Developments/Updates
    2.8 Fotona
        2.8.1 Fotona Details
        2.8.2 Fotona Major Business
        2.8.3 Fotona Vulvar and Vaginal Atrophy Therapy Product and Services
        2.8.4 Fotona Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Fotona Recent Developments/Updates
    2.9 Hologic
        2.9.1 Hologic Details
        2.9.2 Hologic Major Business
        2.9.3 Hologic Vulvar and Vaginal Atrophy Therapy Product and Services
        2.9.4 Hologic Vulvar and Vaginal Atrophy Therapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Hologic Recent Developments/Updates
3 Competitive Environment: Vulvar and Vaginal Atrophy Therapy by Manufacturer
    3.1 Global Vulvar and Vaginal Atrophy Therapy Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Vulvar and Vaginal Atrophy Therapy Revenue by Manufacturer (2018-2023)
    3.3 Global Vulvar and Vaginal Atrophy Therapy Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Vulvar and Vaginal Atrophy Therapy by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Vulvar and Vaginal Atrophy Therapy Manufacturer Market Share in 2022
        3.4.2 Top 6 Vulvar and Vaginal Atrophy Therapy Manufacturer Market Share in 2022
    3.5 Vulvar and Vaginal Atrophy Therapy Market: Overall Company Footprint Analysis
        3.5.1 Vulvar and Vaginal Atrophy Therapy Market: Region Footprint
        3.5.2 Vulvar and Vaginal Atrophy Therapy Market: Company Product Type Footprint
        3.5.3 Vulvar and Vaginal Atrophy Therapy Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Vulvar and Vaginal Atrophy Therapy Market Size by Region
        4.1.1 Global Vulvar and Vaginal Atrophy Therapy Sales Quantity by Region (2018-2029)
        4.1.2 Global Vulvar and Vaginal Atrophy Therapy Consumption Value by Region (2018-2029)
        4.1.3 Global Vulvar and Vaginal Atrophy Therapy Average Price by Region (2018-2029)
    4.2 North America Vulvar and Vaginal Atrophy Therapy Consumption Value (2018-2029)
    4.3 Europe Vulvar and Vaginal Atrophy Therapy Consumption Value (2018-2029)
    4.4 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Consumption Value (2018-2029)
    4.5 South America Vulvar and Vaginal Atrophy Therapy Consumption Value (2018-2029)
    4.6 Middle East and Africa Vulvar and Vaginal Atrophy Therapy Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global Vulvar and Vaginal Atrophy Therapy Sales Quantity by Type (2018-2029)
    5.2 Global Vulvar and Vaginal Atrophy Therapy Consumption Value by Type (2018-2029)
    5.3 Global Vulvar and Vaginal Atrophy Therapy Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global Vulvar and Vaginal Atrophy Therapy Sales Quantity by Application (2018-2029)
    6.2 Global Vulvar and Vaginal Atrophy Therapy Consumption Value by Application (2018-2029)
    6.3 Global Vulvar and Vaginal Atrophy Therapy Average Price by Application (2018-2029)
7 North America
    7.1 North America Vulvar and Vaginal Atrophy Therapy Sales Quantity by Type (2018-2029)
    7.2 North America Vulvar and Vaginal Atrophy Therapy Sales Quantity by Application (2018-2029)
    7.3 North America Vulvar and Vaginal Atrophy Therapy Market Size by Country
        7.3.1 North America Vulvar and Vaginal Atrophy Therapy Sales Quantity by Country (2018-2029)
        7.3.2 North America Vulvar and Vaginal Atrophy Therapy Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe Vulvar and Vaginal Atrophy Therapy Sales Quantity by Type (2018-2029)
    8.2 Europe Vulvar and Vaginal Atrophy Therapy Sales Quantity by Application (2018-2029)
    8.3 Europe Vulvar and Vaginal Atrophy Therapy Market Size by Country
        8.3.1 Europe Vulvar and Vaginal Atrophy Therapy Sales Quantity by Country (2018-2029)
        8.3.2 Europe Vulvar and Vaginal Atrophy Therapy Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Market Size by Region
        9.3.1 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Vulvar and Vaginal Atrophy Therapy Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America Vulvar and Vaginal Atrophy Therapy Sales Quantity by Type (2018-2029)
    10.2 South America Vulvar and Vaginal Atrophy Therapy Sales Quantity by Application (2018-2029)
    10.3 South America Vulvar and Vaginal Atrophy Therapy Market Size by Country
        10.3.1 South America Vulvar and Vaginal Atrophy Therapy Sales Quantity by Country (2018-2029)
        10.3.2 South America Vulvar and Vaginal Atrophy Therapy Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Market Size by Country
        11.3.1 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Vulvar and Vaginal Atrophy Therapy Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 Vulvar and Vaginal Atrophy Therapy Market Drivers
    12.2 Vulvar and Vaginal Atrophy Therapy Market Restraints
    12.3 Vulvar and Vaginal Atrophy Therapy Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Vulvar and Vaginal Atrophy Therapy and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Vulvar and Vaginal Atrophy Therapy
    13.3 Vulvar and Vaginal Atrophy Therapy Production Process
    13.4 Vulvar and Vaginal Atrophy Therapy Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Vulvar and Vaginal Atrophy Therapy Typical Distributors
    14.3 Vulvar and Vaginal Atrophy Therapy Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer